Proteon Pharmaceuticals
Latest round
- Series A
Last raised
- Oct 2017
Total raised
- $4.1M
Investors
- 1
About Proteon Pharmaceuticals
A.Founded in 2005 by Jaroslaw Dastych in Lodz, Poland, Proteon Pharmaceuticals specializes in innovative health solutions for livestock and aquaculture.Proteon Pharmaceuticals specializes in bacteriophage-based solutions for livestock and aquaculture, designed to enhance animal health and sustainability in protein production. Their core products include phage cocktails that prevent and treat bacterial infections in various species, particularly poultry, fish, and dairy cattle. These solutions help modulate the microbiome to support gut health and immune function, thereby improving animal performance and reducing antibiotic reliance.80.A. Future initiatives include launching new products designed to enhance their market offerings and expanding into additional geographic markets, targeting regions that prioritize sustainable agricultural practices.
Who invested in Proteon Pharmaceuticals
1 investor across 1 round
See all investors in Proteon Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 24, 2017
Amount
$4.1M
Investors
Questions about Proteon Pharmaceuticals
Who invested in Proteon Pharmaceuticals?
Proteon Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteon Pharmaceuticals raised?
Proteon Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proteon Pharmaceuticals last raise money?
Proteon Pharmaceuticals's most recent round on record is a Series A, in Oct 2017.
What does Proteon Pharmaceuticals do?
Proteon Pharmaceuticals is a biotechnology company.
Where is Proteon Pharmaceuticals headquartered?
Proteon Pharmaceuticals is headquartered in Lodz, Poland.
Which VCs invest in companies like Proteon Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Proteon Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Proteon Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.